Latest News for: muc16
Edit
Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026
PR Newswire 01 Oct 2026
MUC16 Expression Remained High and Stable Following Standard-of-Care Therapies, Supporting Its Potential Utility in Both Combination Approaches and Relapsed Settings ... Stable MUC16 expression is also observed in paired tumor samples.
- 1